The financial indicators of the Arab Company for Pharmaceuticals and Chemical Industries showed positive results during the first half of the current fiscal year, as the company achieved noticeable growth in its profits.
According to a statement issued today, the company recorded a net profit after tax amounting to 134.55 million EGP during the period from July to the end of December 2025, compared to 106 million EGP during the same period of the previous fiscal year, reflecting an improvement in financial performance.
The company’s sales also increased during the same period to reach 673.7 million EGP, compared to 558.13 million EGP in the corresponding period last year, contributing to a 26.9% increase in profits on an annual basis.